Colonoscopy
Methodology & AI Transparency ⓘ
Colonoscopy Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What are colonoscopy and flexible sigmoidoscopy? Colonoscopy and flexible sigmoidoscopy are procedures that let your doctor look inside your rectum and colon (large intestine).
- 2 Real-world patient consensus: Diagnostic registry K26.4: Colonoscopy is managed within GERD & Stomach.
- 3 Typical cash cost range: Differential triage of Colonoscopy (K26.4) utilizes mucosal protective therapy [Colonoscopy K26.4].
- 4 Top reported side effects / signs: Longitudinal Colonoscopy monitoring tracks H. pylori Stool in Colonoscopy (K26.4: Antigen or Urea) toward Negative (K26.4).
Ask our AI Specialists anything about Colonoscopy
What Is Colonoscopy?
What are colonoscopy and flexible sigmoidoscopy? Colonoscopy and flexible sigmoidoscopy are procedures that let your doctor look inside your rectum and colon (large intestine). They use instruments called scopes. Scopes have a light and a tiny camera attached to a long, thin tube. These procedures let your doctor see problems such as inflamed tissue, ulcers, polyps , and cancer . Colonoscopy checks your entire colon and rectum. Flexible sigmoidoscopy checks the rectum and the lower colon (sigmoid colon) only. What is a virtual colonoscopy? A virtual colonoscopy also looks inside your rectum and part of your colon. But it does not use a scope.
Pathophysiology, Underlying Causes & Clinical Presentation
In Colonoscopy (K26.4), physiological disruption stems from Helicobacter pylori or in Colonoscopy (K26.4: NSAID prostaglandin depletion), Cross-referenced with NIH MeSH (Colonoscopy), informing Acid Reflux, GERD & Upper GI Health protocols that track Hemoglobin & Serum in Colonoscopy (K26.4: Ferritin) (Ferritin > 50 ng/mL (no occult loss) (K26.4)).
Common Symptoms & Clinical Signs
- • Bleeding from your anus (the opening of the rectum through which stool passes out of your body)
- • Changes in your bowel activity, such as diarrhea
- • Presentation of Colonoscopy (K26.4): epigastric burning, early in Colonoscopy (K26.4: satiety, or upper-abdominal)
- • Secondary Colonoscopy clinical sign: chronic throat clearing, in Colonoscopy (K26.4: hoarseness, nocturnal cough,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Colonoscopy Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K26.4 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Acid Reflux, GERD & Upper GI Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: H. pylori Stool in Colonoscopy (K26.4: Antigen or Urea) | Negative (K26.4) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Hemoglobin & Serum in Colonoscopy (K26.4: Ferritin) | Ferritin > 50 ng/mL (no occult loss) (K26.4) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Colonoscopy (K26.4: & Magnesium (chronic) | B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K26.4) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Colonoscopy
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Polyethylene Glycol-3350 and Electrolytes with Flavor Pack Gavilyte - C Tm, Gavilyte - C • RxCUI 966914 | Osmotic Laxative | 75% | $0.0037 | $ 8.65 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Colonoscopy)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Transient alterations in plasma sodium concentrations with NER1006 bowel: What a 1,028-Participant Study Found NER1006 was associated with small, transient increases in sodium levels that were not considered clinically significant. BMC gastroenterology • 2022-09-05 • Phase III Randomized Trial | N = 1,028 | 90/100 | PMID 36064325 ↗ |
| Faster Wake-Up After a Procedure: How a Newer Sedative Compares to Standard Anesthesia The use of remimazolam to achieve sedation in Japanese patients undergoing colonoscopy was more effective than placebo. Digestion • 2024-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39068917 ↗ |
| Can This Approach Help? Inside the Latest Research on Artificial Intelligence Analysis of Endoscopy Outperforms Conventional Endoscopic In 387 subjects, among endoscopically active subjects (MES 2, 3), the CDS was lower in those achieving PMS symptomatic full symptom relief (83.8 vs 186.9, P < 0.0001). The American journal of gastroenterology • 2026-04-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41247057 ↗ |
| New Insights on Real-world benefits and safety of an oral sulfate solution and 3-L polyethylene: What a 340-Participant Study Found The split-dose OSS regimen was not inferior to the split-dose 3-L PEG regimen for the quality of bowel preparation in a Chinese adult population. Gastrointestinal endoscopy • 2023-12-15 • Phase III Randomized Trial | N = 340 | 87/100 | PMID 37422241 ↗ |
| New Insights on Ciprofol (HSK3486) versus propofol for the induction of deep sedation during: What a 289-Participant Study Found Pain on injection was less common in the ciprofol group (4.9% vs. Basic & clinical pharmacology & toxicology • 2022-08-15 • Phase III Randomized Trial | N = 289 | 87/100 | PMID 35653554 ↗ |
Colonoscopy Patient Community & “People Like Me” Threads
Filter Colonoscopy community threads and patient logs by age, biological sex, dosage, and treatment duration.